Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis-Reference-Cited by-同舟云学术

Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis

Published:2019-02-27 Issue:3 Volume:36 Page:384-385
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatr Dermatol

Author:

Wells Leah Ellis¹^ORCID,Evans Tyler²,Hilton Rachael³,Wine Lee Lara⁴^ORCID,Ruth Natasha⁵

Affiliation:

1. Mercer University School of Medicine Macon Georgia

2. University of Nebraska College of Medicine Omaha Nebraska

3. Medical University of South Carolina Charleston South Carolina

4. Pediatric DermatologyMedical University of South Carolina Charleston South Carolina

5. Pediatric RheumatologyMedical University of South Carolina Charleston South Carolina

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pde.13767

Reference5 articles.

1. Nail Psoriasis: A Systematic Evaluation in 313 Children with Psoriasis

2. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy)

3. Long‐term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study;Olivieri I;Clin Exp Rheumatol,2016

4. Secukinumab in the treatment of palmoplantar, nail, scalp, and pustular psoriasis;Armstrong AW;J Clin Aesthet Dermatol,2016

5. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achieving inactive disease in enthesitis-related arthritis with secukinumab following TNF-inhibitor failure;Rheumatology;2023-12-07

2. Nail lichen planus treatment safety;Expert Opinion on Drug Safety;2023-12

3. Secukinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients aged six years and older;Expert Review of Clinical Immunology;2023-05-23

4. Anti-IL17 treatment in childhood chronic rheumatic diseases;Expert Opinion on Biological Therapy;2023-05-04

5. Systemic treatment of psoriasis in special population;Indian Journal of Dermatology, Venereology and Leprology;2023-05-01